Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDukemount Capi. Regulatory News (DKE)

  • There is currently no data for DKE

Issue of Equity

22 Apr 2020 07:00

RNS Number : 4107K
Dukemount Capital PLC
22 April 2020
 

Dukemount Capital PLC

22 April 2020

 

 

 

Dukemount Capital Plc

("Dukemount" or "the Company")

 

Placing to Raise ÂŁ255,034.50

 

 

Dukemount Capital Plc ("Dukemount") (EPIC: DKE), the property management and long dated income provider is pleased to announce that it has raised ÂŁ255,034.50 with the issue of 72,867,000 new ordinary shares (the "Placing"), before expenses, in order to bring in additional expertise to position the company for growth within its expanded focus of Education and Healthcare.

 

Fundraise

 

The Company has raised, in aggregate, ÂŁ255,034.50 before expenses, by way of a placing of 72,867,000 new ordinary shares (the "Placing Shares") at a price of 0.35 pence per share (the "Issue Price), the maximum number of shares that can be issued under its existing authorities for cash. The net proceeds of the Fundraise will be used by the Company to engage experienced people familiar with the property sector (and in particular with large scale projects in the education and healthcare sectors) and for general working capital purposes.

 

The issue price represents a discount of approximately 22.22% to the closing price of the Company's ordinary shares on the Standard Listing segment of the Official List of the UK Listing Authority of 0.45 pence on 21 April 2020, being the latest practicable date prior to this announcement. The Placing Shares represent approximately 19.9% of the Company's issued share capital.

 

The Placing was conducted by Peterhouse Capital Limited acting as broker to the Company.

 

Corporate Update

 

The Company's existing projects in North West England are continuing to move towards completion in the coming months despite the extraordinary national distractions since the third quarter of 2019. The impact of COVID-19 is a matter of regular review by the Company.

 

The additional focus of Education and Healthcare has kept the board and its advisors very busy. The time has now arrived to increase the headcount within Dukemount, due to the potential increased size and complications of the deals being discussed.

 

Admission and Total Voting Rights

 

The Fundraise is conditional only on the admission of the Placing Shares to trading on the Standard List.

 

Application will be made for Admission of the Placing Shares which is expected to occur at 8.00 a.m. on or around 27th April 2020.

 

Following Admission, the Company will have 439,033,666 ordinary shares in issue, none of which will be held in treasury. Accordingly, the total number of voting rights in the Company will be 439,033,666 and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Dukemount Chairman Geoffrey Dart said; "The talks we are having with regards to Education and Healthcare have confirmed there is a large appetite for project opportunities within the UK. In order to efficiently execute our plans in these discussions we need to bring in additional staff to move quickly from due diligence talks to project initiation, freeing the board to look at additional opportunities."

 

For further information, please visit www.dukemountcapitalplc.com or contact:

 

Dukemount Capital Plc

Via St Swithins PR

Geoffrey Dart

 

 

 

St Swithins PR (Media and Investor Enquiries)

Tel: +44 (0) 1732 521132

Gary Middleton

gary@swithins.com

 

 

 

 

Peterhouse Capital Limited

Tel: +44 (0) 207 469 0930

Lucy Williams/Duncan Vasey

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEKKDBQABKDNQB
Date   Source Headline
31st Jan 20254:38 pmRNSTR1: Notification of major holdings
29th Jan 202512:58 pmRNSNew Strategy and Business Updates
24th Jan 20255:03 pmRNSAUDITED RESULTS TO 30 SEPTEMBER 2024
14th Nov 20243:16 pmRNSHolding(s) in Company
29th Oct 20249:46 amRNSTR1: Notification of Major Holdings
28th Oct 20242:30 pmRNSTR-1: Notification of major holdings
17th Oct 20243:17 pmRNSBoard Changes, Placing, Issue of CLNs and Warrants
27th Jun 202410:06 amRNSHalf-year Report
20th May 20244:29 pmRNSHolding(s) in Company
9th May 202411:41 amRNSHolding(s) in Company
3rd May 202411:28 amRNSTR1 - NOTIFICATION OF MAJOR HOLDINGS
18th Apr 20243:09 pmRNSResult of AGM
21st Mar 20247:00 amRNSNotice of AGM and a conditional subscription
8th Mar 20244:29 pmRNSTR-1: Standard form notification of major holdings
7th Mar 202410:51 amRNSUpdate on the Facility Agreement and TVR
5th Mar 202412:45 pmRNSHolding(s) in Company
4th Mar 20241:16 pmRNSCapitalisation of Loan, Issue of Equity & Warrants
26th Feb 202410:04 amRNSHolding(s) in Company
30th Jan 202412:09 pmRNSFinal Results
12th Jan 20242:13 pmRNSResult of AGM
14th Dec 20239:56 amRNSNotice of AGM
12th Sep 20237:44 amRNSProposed lifting of suspension and other updates
16th Jun 20237:00 amRNSHalf-year Report
9th Jun 202310:17 amRNSFinal Results
22nd Nov 20227:06 amRNSChange of Broker
1st Nov 20228:03 amRNSTemporary Suspension
28th Oct 20224:40 pmRNSSecond Price Monitoring Extn
28th Oct 20224:35 pmRNSPrice Monitoring Extension
28th Oct 20229:32 amRNSIssue of Equity
27th Oct 20224:41 pmRNSSecond Price Monitoring Extn
27th Oct 20224:36 pmRNSPrice Monitoring Extension
26th Oct 20229:32 amRNSIssue of Equity
20th Oct 20229:26 amRNSIssue of Equity
19th Oct 202212:33 pmRNSHolding(s) in Company
19th Oct 20227:00 amRNSHolding(s) in Company
13th Oct 20222:05 pmRNSSecond Price Monitoring Extn
13th Oct 20222:00 pmRNSPrice Monitoring Extension
13th Oct 202211:05 amRNSSecond Price Monitoring Extn
13th Oct 202211:00 amRNSPrice Monitoring Extension
12th Oct 20227:00 amRNSIssue of Equity
11th Oct 20227:00 amRNSFurther Funding and Funding Restructuring
5th Oct 20229:05 amRNSSecond Price Monitoring Extn
5th Oct 20229:00 amRNSPrice Monitoring Extension
5th Oct 20227:20 amRNSCompletion of sale
23rd Feb 20224:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:35 pmRNSPrice Monitoring Extension
28th Jan 20221:43 pmRNSInterim Results
4th Jan 20224:36 pmRNSHolding(s) in Company
29th Oct 20212:16 pmRNSFinal Results
7th Oct 202110:08 amRNSChange of Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.